CD8A and ovarian cancer: This further argues that the cell-autonomous function of MAP3K8 in ovarian cancers could be dominant over the anti-tumour effect mediated by CD8+ cytotoxic-T lymphocytes or by tumour necrosis factor-α-producing M1 macrophages.